Cargando…

Advances in the targeted therapy of liposarcoma

Liposarcoma (LPS) is the most common type of soft-tissue sarcoma. Complete surgical resection is the only curative means for localized disease; however, both radiation and conventional cytotoxic chemotherapy remain controversial for metastatic or unresectable disease. An increasing number of trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Zhonghai, Yu, Xiongfei, Wang, Haohao, Wang, Haiyong, Zhang, Jing, Li, Guangliang, Cao, Jiang, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293924/ https://www.ncbi.nlm.nih.gov/pubmed/25609980 http://dx.doi.org/10.2147/OTT.S72722

Ejemplares similares

LncRNA UCA1 in anti-cancer drug resistance
por: Wang, Haohao, et al.
Publicado: (2017)

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer
por: Zhang, Junbin, et al.
Publicado: (2020)

Gut microbiota shifts in patients with gastric cancer in perioperative period
por: Liang, Weiren, et al.
Publicado: (2019)

BP-1-102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways
por: Jiang, Xiaoxia, et al.
Publicado: (2019)

GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer
por: Ding, Yongfeng, et al.
Publicado: (2020)

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
por: Lu, Jun, et al.
Publicado: (2015)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
por: Gu, Yu, et al.
Publicado: (2016)

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2019)

Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
por: Chen, Xiangheng, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
por: Jiang, Haiping, et al.
Publicado: (2022)

Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
por: Zhang, Junbin, et al.
Publicado: (2020)

Recent advances in the management of liposarcoma
por: Nassif, Nadar A., et al.
Publicado: (2016)

Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets
por: Lu, Jun, et al.
Publicado: (2021)

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases
por: Jin, Ketao, et al.
Publicado: (2011)

Recent advances in the understanding and management of liposarcoma
por: Haddox, Candace L, et al.
Publicado: (2021)

Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma
por: Casadei, Lucia, et al.
Publicado: (2022)

FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway
por: Chen, Yanyan, et al.
Publicado: (2017)

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
por: Wang, Haiyong, et al.
Publicado: (2017)

Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis (Adv. Sci. 30/2023)
por: Lin, Wu, et al.
Publicado: (2023)

Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis
por: Lin, Wu, et al.
Publicado: (2023)

Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
por: Tseng, William W., et al.
Publicado: (2013)

Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment
por: Yang, Lingge, et al.
Publicado: (2020)

The Essential Factors of Establishing Patient-derived Tumor Model
por: Chen, Chuanzhi, et al.
Publicado: (2021)

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
por: Gu, Yu, et al.
Publicado: (2014)

Liposarcomas of the mediastinum
por: Suster, David Ilan, et al.
Publicado: (2020)

Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022)

Host miRNAs-microbiota interactions in gastric cancer
por: Yang, Yan, et al.
Publicado: (2022)

A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics
por: Wang, Haiyong, et al.
Publicado: (2021)

Potential targeted therapeutic approaches in liposarcoma
por: Kanojia, Deepika, et al.
Publicado: (2016)

Management of myxoid liposarcoma of the extremity
por: Tfayli, Yehia, et al.
Publicado: (2021)

Occurrence of colonic liposarcoma after retroperitoneal liposarcoma
por: Choi, Jin Hwa, et al.
Publicado: (2015)

Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers
por: Chen, Yanyan, et al.
Publicado: (2020)

Liposarcoma: Molecular Genetics and Therapeutics
por: Conyers, Rachel, et al.
Publicado: (2011)

PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma
por: Toivanen, Kirsi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iobkpo0p852r0r0s5o0kgndp80